First Patient Dosed in Phase 2 Trial to Evaluate AU-011 for Choroidal Melanoma
cocoparisienne / Pixabay

First Patient Dosed in Phase 2 Trial to Evaluate AU-011 for Choroidal Melanoma

  Recently, clinical-stage biopharmaceutical company Aura Biosciences announced a Phase 2 clinical trial to determine the safety, efficacy, and tolerability of AU-011 for patients with choroidal melanoma. Currently, Aura Biosciences…

Continue Reading First Patient Dosed in Phase 2 Trial to Evaluate AU-011 for Choroidal Melanoma
September 21-25 is Global ITP Awareness Week: Spreading Rare Disease Awareness
source: pixabay.com

September 21-25 is Global ITP Awareness Week: Spreading Rare Disease Awareness

In 2020, September 21-25 will be recognized as Global Immune Thrombocytopenia (ITP) Awareness Week. The week will aim to help spread awareness about ITP around the world both in the…

Continue Reading September 21-25 is Global ITP Awareness Week: Spreading Rare Disease Awareness